Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on the "Receptor Activator of Nuclear Factor-kappa B Ligand / Osteoprotégérine (RANKL / OPG) System in Patients Living With Type II Diabetes
Clinical trial NCT04893135 · COMPLETED
Trial details
- NCT number
- NCT04893135
- Sponsor
- Centre Hospitalier Sud Francilien
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-11
- Primary completion
- 2022-10-11
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.